Trademarkia Logo

Canada

C$
Trademark Search in Canada
NOVEOME

View On IC.GC.CA

NOVEOME
REGISTERED

on 29 Apr 2020

Last Applicant/ Owned by

NOVEOME BIOTHERAPEUTICS INC. A LEGAL ENTITY

100 Technology Drive, Suite 200Pittsburgh, PA 15219

US

Serial Number

1773111 filed on 18th Mar 2016

Registration Number

TMA1077828 registered on 29th Apr 2020

Registration expiry Date

29th Apr 2030

Correspondent Address

RICHES, MCKENZIE & HERBERT LLP

SUITE 18002 BLOOR STREET EASTTORONTO

ONTARIO

CA

M4W3J5

NOVEOME

Trademark usage description

pharmaceutical preparations consisting primarily of amniotic cells for modulating tissue rejection, and repairing damaged tissues; pharmaceutical prep Read More

Classification Information

Class [005]
Pharmaceutical preparations consisting primarily of amniotic cells for modulating tissue rejection, and repairing damaged tissues; pharmaceutical preparations consisting primarily of cell growth medium conditioned by amniotic cells for repairing damaged tissue, and restoring tissue homeostasis; pharmaceutical preparations for modulating tissue rejection, repairing damaged tissues, and restoring tissue homeostasis; pharmaceutical preparations for the treatment of disease, namely, psoriasis, eczema, atopic dermatitis, contact dermatitis, acne vulgaris, acne rosacea, hidradenitis suppurativa, herpes simplex, herpes zoster, ringworm, folliculitis, furnuncles, multiple sclerosis, acute disseminated encephalomyelitis, neuromyelitis optica (Devic's disease), transverse myelitis, optic neuritis, CNS vasculitis, neurosarcoidosis, neuropsychiatric manifestations of systemic lupus erythematosus, HIV-associated dementia, human T-lymphotrophic virus-associated neurological disorders, West Nile virus infection of the CNS , inflammation associated with Alzheimer's Disease, Huntington's Disease, Parkinson's disease, traumatic brain injury, chronic traumatic encephalopathy, peripheral neuropathy, neuromyelitis optica (Devic's disease), optic neuritis, glaucoma, cataract surgery, corneal defects, persistent corneal defects, allergic conjunctivitis, uveitis, scleritis, episcleritis, keratitis, orbital pseudotumor, retinal vasculitis, chronic conjunctivitis. ocular cicatricial pemphigoid, Mooren's corneal ulcer, Birdshot retinochoroidopathy, Vogt-Koyanagi-Harada syndrome, sympathetic ophthalmia, dry eye syndrome, osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, fibromyalgia, scleroderma, spondyloarthropathies, gout, infectious arthritis, polymyalgia rheumatic, polymyositis, dermatomyositis, psoriatic arthritis, bursitis, tendinitis, tendonitis, pelvic inflammatory disease, interstitial cystitis, digestive diseases comprising inflammatory bowel disease, ulcerative colitis, Crohn's disease, regional enteritis, terminal ileitis, granulomatous ileocolitis, necrotizing enterocolitis, celiac diseases, diverticulitis, hemorrhoids, anal fissures, cardiovascular disease, lymphangitis, thyroiditis, pneumonia, acute respiratory distress syndrome, chronic obstructive pulmonary diseases, emphysema, CIAS1-related Autoinflammatory Periodic Syndromes (CAPS), Familial Cold Autoinflammatory Syndrome (FCAS), Muckle-Wells Syndrome (MWS), Neonatal Onset Multisystem Inflammatory Disease (NOMID), Behcet's syndrome, allergic reactions, burns, Graft Versus Host Disease (GVHD), Host Versus Graft Disease (HVGD), juvenile (Type I) diabetes, systemic lupus erythematosus, Graves' disease, autoimmune hemolytic anemia, bullous pemphigoid, Hashimoto's thyroiditis, myasthenia gravis, pemphigus, pernicious anemia, Type 1 diabetes, multiple sclerosis, lupus, rheumatoid arthritis

Classification kind code

10

Class [042]
Medical research; pharmaceutical research and development

Classification kind code

10

Mark Details

Serial Number

1773111

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 21st Oct 2019		Approved
Submitted for opposition 15
on 7th May 2019		Correspondence Created
Submitted for opposition 15
on 6th Sept 2018		Correspondence Created
Submitted for opposition 15
on 2th Mar 2018		Correspondence Created
Submitted for opposition 15
on 2th Jun 2017		Correspondence Created
Submitted for opposition 22
on 26th Aug 2016		Search Recorded
Submitted for opposition 20
on 26th Aug 2016		Examiner's First Report
Submitted for opposition 31
on 22nd Mar 2016		Formalized
Submitted for opposition 1
on 21st Mar 2016		Created
Submitted for opposition 30
on 18th Mar 2016		Filed